Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: La Du BN

Name Class
La Du BNFull_nameLa Du Bert N
CommentBert Nicholas La Du, Jr. , M.D., Ph.D. 1920 - January 30, 2005. Dr. Bert N. La Du, Professor Emeritus of Pharmacology at the University of Michigan, was President of ASPET from 1978-1979. Dr. La Du's primary research interests were the biochemistry of drug metabolism and pharmacogenetics. He pioneered work on variants of Butyrylcholinesterase and Paraoxonases. A tribute to his work was given by Oksana Lockridge at the 6th international meeting on cholinesterases (San Diego) in 1998 (Lockridge 1998) and ASPET LaDu.pdf
First_nameBert N
AddressMailDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor. MI 48109-0626
CountryUSA
URL_WWW//bioweb.supagro.inra.fr/esther/PapersSupData/OtherPDF/LaDu.pdf
PaperHidaka_1992_Rinsho.Byori_40_535
La Du_1989_Trends.Pharmacol.Sci_10_309
La Du_1972_Fed.Proc_31_1276
La Du_1972_Adv.Biol.Skin_12_95
Clark_1968_Ann.N.Y.Acad.Sci_151_710
Primo-Parmo_1997_Pharmacogenet_7_27
La_2001_Drug.Metab.Dispos_29_566
Allderdice_1991_Genomics_11_452
Bartels_1992_Am.J.Hum.Genet_50_1104
Bartels_1992_Am.J.Hum.Genet_50_1086
Nogueira_1992_Am.J.Hum.Genet_51_821
Primo-Parmo_1996_Am.J.Hum.Genet_58_52
Arpagaus_1991_J.Biol.Chem_266_6966
McGuire_1989_Proc.Natl.Acad.Sci.U.S.A_86_953
Nogueira_1990_Am.J.Hum.Genet_46_934
Satoh_2002_Drug.Metab.Dispos_30_488
Nogueira_1989_Am.J.Hum.Genet_45_A210
Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617
Aviram_1999_Free.Radic.Biol.Med_26_892
Aviram_1998_J.Clin.Invest_101_1581
Brushia_2001_J.Lipid.Res_42_951
Draganov_2010_Adv.Exp.Med.Biol_660_89
Draganov_2005_J.Lipid.Res_46_1239
Primo-Parmo_1996_Genomics_33_498
Rosenblat_2003_Arterioscler.Thromb.Vasc.Biol_23_468
Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214
Teiber_2003_Biochem.Pharmacol_66_887
Teiber_2004_J.Lipid.Res_45_2260
Hajra_1991_3rd.ChE.Meeting.LaGrandeMotte__201
Adkins_1991_3rd.ChE.Meeting.LaGrandeMotte__196
Arpagaus_1991_3rd.ChE.Meeting.LaGrandeMotte__194
Lockridge_1991_3rd.ChE.Meeting.LaGrandeMotte__193
La Du_1991_3rd.ChE.Meeting.LaGrandeMotte__192
Bartels_1991_3rd.ChE.Meeting.LaGrandeMotte__191
Bartels_1991_3rd.ChE.Meeting.LaGrandeMotte__190
Jensen_1991_3rd.ChE.Meeting.LaGrandeMotte__189
Sorenson_1995_Proc.Natl.Acad.Sci.U.S.A_92_7187
Naguib_1999_Anesth.Analg_89_1579
Teiber_2007_Arch.Biochem.Biophys_461_24
Billecke_1999_Chem.Biol.Interact_119-120_251
Doorn_1999_Chem.Biol.Interact_119-120_235
La Du_1999_Chem.Biol.Interact_119-120_379
La Du_1999_Chem.Biol.Interact_119-120_599
Sorenson_1999_Chem.Biol.Interact_119-120_243
Greenberg_1995_Anesth.Analg_81_419
Arpagaus_1990_Biochemistry_29_124
Bartels_1990_Nucleic.Acids.Res_18_6171
La Du_1990_Clin.Biochem_23_423
La Du_1991_Cell.Mol.Neurobiol_11_79
Gan_1991_Drug.Metab.Dispos_19_100
Smolen_1991_Drug.Metab.Dispos_19_107
McAlpine_1991_Nucleic.Acids.Res_19_5088
Hajra_1992_Pharmacogenet_2_78
Jensen_1992_Pharmacogenet_2_234
Nogueira_1993_Pharmacogenet_3_144
La Du_1993_Chem.Biol.Interact_87_25
Swift_1966_Lancet_1_513
La Du_1970_Adv.Enzyme.Regul_9_317
Lockridge_1978_J.Biol.Chem_253_361
Lockridge_1979_J.Biol.Chem_254_8324
Lockridge_1980_J.Pharmacol.Exp.Ther_215_1
Valentino_1981_Biochem.Pharmacol_30_1643
Myers_1982_Drug.Metab.Dispos_10_279
Lockridge_1982_J.Biol.Chem_257_12012
Eckerson_1983_Biochem.Genet_21_93
Eckerson_1984_Drug.Metab.Dispos_12_57
La Du_1984_Fed.Proc_43_2338
Lockridge_1986_Biochem.Genet_24_485
La Du_1986_Fed.Proc_45_2965
Lockridge_1987_J.Biol.Chem_262_12945
McTiernan_1987_Proc.Natl.Acad.Sci.U.S.A_84_6682
La Du _1972_Annu.Rev.Med_23_453
La Du_1995_Acta.Anaesthesiol.Scand_39_139
Haley_1999_Toxicol.Appl.Pharmacol_157_227

Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer